Attachment

AstraZeneca AZD7442 Monoclonal Intravenous New Q3 2021 Antibody Cocktail Brii Biosciences Brii-196 & Brii- Monoclonal Intravenous New Q2 2021 Antibody Cocktail Eli Lilly LY-CoV-555 Monoclonal Intravenous New Q4 2020 Antibody Single GSK-Vir VIR-7831 Monoclonal Intravenous New Q2 2021 Antibody Single ACTIV-4 Outpatients BMS/Pfizer Apixaban Anticoagulant Oral Repurposed Q4 2021 BMS/Pfizer Aspirin Antiplatelet Oral Repurposed 4 2021 Inpatients Other Un-fractionated -- Anticoagulant Intravenous Repurposed Q2 2021 (UF) Heparin Other Low Molecular -- Anticoagulant Injection Repurposed Q2 2021 Weight (LMW) Heparin ACTIV-5 Inpatient AbbVie/Boehringer Risankizumab Immune Intravenous Repurposed Q4 2021 Ingelheim Modulator Humanigen Lenzilumab Immune Intravenous New Q4 2021 Modulator ACTIV-Associated Adaptive COVID-19 Treatment Trial (ACTT) Inpatient Gilead Remdesivir Antiviral Intravenous Repurposed 4 2020 Eli Lilly Remdesivir and -- Antiviral/Anti- Intravenous/Oral Repurposed Q4 2020 Baricitinib Inflammatory Eli Lilly Remdesivir and Antiviral/Anti- Intravenous/Oral Repurposed Baricitinib or Inflammatory/ Dexamethasone Immune Modulator 2/3